20 results
424B3
NDRA
ENDRA Life Sciences Inc
5 Jun 24
Prospectus supplement
8:20am
offering or registered direct offering during the term of the engagement with the Placement Agent or within six (6) months following the expiration … or termination of the engagement with the Placement Agent.
Other Relationships
The Placement Agent and its respective affiliates may in the future engage
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
20 May 24
ENDRA Provides Update Following In-person Meeting with FDA
8:05am
to the FDA as a next step prior to initiating the study.
"ENDRA's new regulatory approach is focused on close engagement with the FDA to ensure
8-K
EX-1.1
1dxxt ult016tz
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-1.1
h259c2vgyyy1mzmca
27 Mar 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-10.1
7ia0el1j0
27 Dec 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.2
6ksu2 zyy
27 Dec 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-1.1
8k8gfd9kd h5tvx
13 Nov 18
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-1.1
uokriccc59 z29a3
16 Oct 18
ENDRA Life Sciences Inc. Announces Proposed Public Offering of Common Stock
4:05pm
- Prev
- 1
- Next